FDA Denies Alnylam Pharmaceuticals’ Expansion Plans for Onpattro Treatment
The FDA has denied Alnylam Pharmaceuticals' request to expand the use of its siRNA injection Onpattro for the treatment of [...]
FDA Advisory Panel Backs Removal of Non-Circulating Flu Strain from Vaccines, Amid Timeline Concerns
The FDA's vaccine advisory panel has supported removing a strain of influenza viruses that no longer circulates, known as B/Yamagata, [...]
Global Real-World Data Market Forecast to Grow at 14.4% CAGR from 2023 to 2030, Fueled by Increased Demand for Evidence-based Medicine and Technological Advancements
The global real-world data (RWD) market, which encompasses data collected outside of clinical trials, is forecasted to grow at a [...]
AbbVie Acquires Mitokinin for $110M Upfront to Enhance its Neuroscience Pipeline
Pharmaceutical company AbbVie has purchased biotech Mitokinin for $110 million upfront, potentially adding $545 million in milestone payments. The deal [...]
Cancer Drug Shortages Easing but Still a Challenge, Survey Shows
The issue of cancer drug shortages in the U.S. appears to be easing slightly but persists, according to a survey [...]
Public Health Policies Aligned with Climate Change Mitigation: An Investment for Health and Economic Benefits
Investing in public health policies aligning with climate change mitigation measures is financially beneficial and crucial for human and planetary [...]
Federal Judge Upholds Medicare Drug Price Negotiation Provisions of Inflation Reduction Act
A federal judge has upheld the Medicare drug price negotiation provisions of the Inflation Reduction Act (IRA), opposing the Chamber [...]
American Medical Association Issues Unique PLA Code to Oxford BioDynamics
Oxford BioDynamics PLC has been assigned a unique Proprietary Laboratory Analysis Code (PLA Code) by the American Medical Association's CPT [...]
Trends Projected to Reshape the Healthcare Landscape in 2024
Several societal drivers will shape the healthcare landscape in 2024, including a longer-living population, transformative technologies, and global economic uncertainty. [...]
Novo Nordisk Joins Biopharma Companies Challenging Drug Price Negotiations in Inflation Reduction Act
Novo Nordisk and numerous other biopharma companies are challenging drug price negotiation provisions in the Inflation Reduction Act. Novo has [...]
2023 Nobel Prize in Medicine Awarded to mRNA Researchers Katalin Karikó and Drew Weissman
Katalin Karikó and Drew Weissman, two pioneers of mRNA research, were awarded the 2023 Nobel Prize in Medicine or Physiology [...]
Johnson & Johnson’s Drug Combination Improves Progression-Free Survival in Lung Cancer Trial Against AstraZeneca’s Therapy
The Mariposa study showed that a combination of two Johnson & Johnson (J&J) drugs, Rybrevant, and lazertinib, was successful in [...]
Integration of Digital Targeting in Addressable TV: Implications for Healthcare Marketers
Addressable TV—which uses digital targeting and measurements for television advertisements—is changing the marketing landscape. It allows healthcare marketers to reach [...]
Philip Morris Introduces LEVIA: A Tobacco-Free Alternative for IQOS Device
Philip Morris International (PMI) has announced a new product for its IQOS 'heat-not-burn' device: a tobacco-free stick named LEVIA. The [...]
Unveiling the NHS Data Landscape: First Comprehensive Mapping for Improved Transparency and Efficiency
Researchers from the Institute of Global Health Innovation at Imperial College London have mapped and evaluated all electronic data flows [...]
Roche Acquires Two RNA-Targeted Drug Programs for Alzheimer’s and Huntington’s from Ionis Pharmaceuticals
Roche has obtained two RNA-targeted drug programs for Alzheimer's and Huntington's diseases from Ionis Pharmaceuticals. The deal involves a $60 [...]
Cell & Gene Therapies – Beginning with the End in Mind
This webinar discusses how early stage planning taking into account commercial production, logistics, reimbursement, and health inequities can lead to successful approvals and market adoption.
Galecto Laying Off 70% of Staff and Exploring Strategic Alternatives after Failed Lung Disease Drug Trial
Boston-based biotech firm Galecto plans to lay off 29 employees, approximately 70% of its workforce, after [...]
Class-Action Lawsuit Targets Johnson & Johnson and IBM after Data Breach
Johnson & Johnson and IBM face a proposed class-action lawsuit following a data breach at J&J’s [...]
Plans to Remove Medical Debt from Credit Reports and Further Measures Proposed to Alleviate Medical Debt Burden
The White House has announced a plan by the Consumer Financial Protection Bureau (CFPB) to exclude [...]
AstraZeneca and Daiichi Sankyo Plan Approval Filing for Breast Cancer Treatment Following Promising Trial Results
AstraZeneca and Daiichi Sankyo plan to seek approval for their breast cancer treatment datopotamab deruxtecan (Dato-DXd) [...]
GA4GH Announces Ten New International Genomic Data Initiatives
The Global Alliance for Genomics and Health (GA4GH) has announced ten new international genomic data initiatives, [...]
Leveraging Companion Apps in Pharma: From Short-Term Profit to Long-Term Progress
The pharmaceutical industry often focuses on short-term progress, but patient companion apps offer significant medium- and [...]
The Illusions of the U.S. Pharmaceutical Industry: Misdirection in Drug Pricing, Innovation, and Regulation
The U.S. biopharmaceutical industry uses subtle illusion techniques similar to magicians to distract Americans from truths [...]
Risk of Long Covid Increases with Each COVID-19 Reinfection, Indicates Study
The coronavirus pandemic has prompted questions about reinfection and the risk of developing "long Covid" characterized [...]